96 related articles for article (PubMed ID: 8046620)
1. Preparation and biodistribution of copper-67 complexes with tetradentate Schiff-base ligands.
John EK; Bott AJ; Green MA
J Pharm Sci; 1994 Apr; 83(4):587-90. PubMed ID: 8046620
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships for metal-labeled blood flow tracers: comparison of keto aldehyde bis(thiosemicarbazonato)copper(II) derivatives.
John EK; Green MA
J Med Chem; 1990 Jun; 33(6):1764-70. PubMed ID: 2342070
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of a monocationic copper(II) radiopharmaceutical derived from N-(2-pyridylmethyl)-N'-(salicylaldimino)-1,3-propanediamine.
Sri-Aran M; Mathias CJ; Lim JK; Green MA
Nucl Med Biol; 1998 Feb; 25(2):107-10. PubMed ID: 9468024
[TBL] [Abstract][Full Text] [Related]
4. Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands.
Sun X; Wuest M; Weisman GR; Wong EH; Reed DP; Boswell CA; Motekaitis R; Martell AE; Welch MJ; Anderson CJ
J Med Chem; 2002 Jan; 45(2):469-77. PubMed ID: 11784151
[TBL] [Abstract][Full Text] [Related]
5. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism.
Rogers BE; Anderson CJ; Connett JM; Guo LW; Edwards WB; Sherman EL; Zinn KR; Welch MJ
Bioconjug Chem; 1996; 7(4):511-22. PubMed ID: 8853465
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of copper-labeled bifunctional chelate-albumin conjugates for blood pool imaging.
Anderson CJ; Rocque PA; Weinheimer CJ; Welch MJ
Nucl Med Biol; 1993 May; 20(4):461-7. PubMed ID: 8504288
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of copper radiopharmaceuticals with mixed bis(thiosemicarbazone) ligands.
Ackerman LJ; West DX; Mathias CJ; Green MA
Nucl Med Biol; 1999 Jul; 26(5):551-4. PubMed ID: 10473194
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and biodistribution of new 99mTc Oxo and nitrido complexes of unsaturated tetradentate (N2S2)ligands.
Coulais Y; Cros G; Darbieu MH; Gantet P; Tafani JA; Vende D; Pasqualini R; Guiraud R
Nucl Med Biol; 1993 Apr; 20(3):263-8. PubMed ID: 8485485
[TBL] [Abstract][Full Text] [Related]
9. A potential copper radiopharmaceutical for imaging the heart and brain: copper-labeled pyruvaldehyde bis(N4-methylthiosemicarbazone).
Green MA
Int J Rad Appl Instrum B; 1987; 14(1):59-61. PubMed ID: 3583756
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biodistribution of a Lipophilic 64Cu-labeled monocationic Copper(II) complex.
Packard AB; Kronauge JF; Barbarics E; Kiani S; Treves ST
Nucl Med Biol; 2002 Apr; 29(3):289-94. PubMed ID: 11929697
[TBL] [Abstract][Full Text] [Related]
11. Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.
Wallhaus TR; Lacy J; Whang J; Green MA; Nickles RJ; Stone CK
J Nucl Med; 1998 Nov; 39(11):1958-64. PubMed ID: 9829589
[TBL] [Abstract][Full Text] [Related]
12. [Radiolabeling and biodistribution of 62Cu-dithiocarbamate--an application for the new 62Zn/62Cu generator].
Matsumoto K; Fujibayashi Y; Konishi J; Yokoyama A
Radioisotopes; 1990 Nov; 39(11):482-6. PubMed ID: 1964237
[TBL] [Abstract][Full Text] [Related]
13. Structure-distribution relationships for metal-labeled myocardial imaging agents: comparison of a series of cationic gallium (III) complexes with hexadentate bis(salicylaldimine) ligands.
Tsang BW; Mathias CJ; Fanwick PE; Green MA
J Med Chem; 1994 Dec; 37(25):4400-6. PubMed ID: 7996552
[TBL] [Abstract][Full Text] [Related]
14. In vivo behavior of copper-64-labeled methanephosphonate tetraaza macrocyclic ligands.
Sun X; Wuest M; Kovacs Z; Sherry AD; Motekaitis R; Wang Z; Martell AE; Welch MJ; Anderson CJ
J Biol Inorg Chem; 2003 Jan; 8(1-2):217-25. PubMed ID: 12459917
[TBL] [Abstract][Full Text] [Related]
15. Application of the new zinc-62/copper-62 generator: an effective labeling method for 62Cu-PTSM.
Matsumoto K; Fujibayashi Y; Yonekura Y; Wada K; Takemura Y; Konishi J; Yokoyama A
Int J Rad Appl Instrum B; 1992 Jan; 19(1):39-44. PubMed ID: 1577613
[TBL] [Abstract][Full Text] [Related]
16. In vivo evaluation of copper-64-labeled monooxo-tetraazamacrocyclic ligands.
Sun X; Kim J; Martell AE; Welch MJ; Anderson CJ
Nucl Med Biol; 2004 Nov; 31(8):1051-9. PubMed ID: 15607487
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo structure-property relationship of (68)Ga-labeled Schiff base derivatives for functional myocardial pet imaging.
Thews O; Zimny M; Eppard E; Piel M; Bausbacher N; Nagel V; Rösch F
Mol Imaging Biol; 2014 Dec; 16(6):802-12. PubMed ID: 24888405
[TBL] [Abstract][Full Text] [Related]
18. In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62.
Mathias CJ; Welch MJ; Green MA; Diril H; Meares CF; Gropler RJ; Bergmann SR
J Nucl Med; 1991 Mar; 32(3):475-80. PubMed ID: 2005455
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of gallium-68 tris(2-mercaptobenzyl)amine: a complex with brain and myocardial uptake.
Cutler CS; Giron MC; Reichert DE; Snyder AZ; Herrero P; Anderson CJ; Quarless DA; Koch SA; Welch MJ
Nucl Med Biol; 1999 Apr; 26(3):305-16. PubMed ID: 10363802
[TBL] [Abstract][Full Text] [Related]
20. Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET.
Green MA; Klippenstein DL; Tennison JR
J Nucl Med; 1988 Sep; 29(9):1549-57. PubMed ID: 3261785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
